Skip to Main Content
Pharmacist's Letter Canada
Menu
  • Login Subscribe
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Patient Education
  • CE & Training
    • CE Organizer
    • All Courses
    • All Courses - PDF
    • Live CE Calendar
    • Print Statements
    • Licenses
    • Additional Requirements
    • Exemptions
  • New Drugs
  • TRC Sites
    • Hospital Pharmacist's Letter
    • Hospital Prescriber's Letter
    • Natural Medicines
    • Nurse's Letter
    • Pharmacist's Letter
    • Pharmacy Technician's Letter
    • Pharmacy Technician's Letter Canada
    • Prescriber's Letter
  • Help
    • FAQs
    • Enterprise Admin Support
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Infectious Diseases
  4. STIs
  5. Hepatitis

Hepatitis

  • Antimicrobial Stewardship (10)
  • Fever (3)
  • Fungal Infections (6)
  • H1N1 (Swine) Influenza (38)
  • HIV & AIDS (86)
  • Infections (27)
  • Lower Respiratory Tract Infections (74)
  • Measles (2)
  • MRSA (4)
  • Other (205)
  • Resources (519)
  • STIs (94)
    • Chlamydia (6)
    • Genital Herpes (Herpes simplex) (2)
    • Gonorrhea (15)
    • Hepatitis (34)
    • Herpes (3)
    • HPV (24)
    • Other STIs (3)
    • Prevention (18)
    • Syphilis (6)
    • Trichomonas (2)
  • Skin/Soft Tissue Infections (71)
  • Thrush (1)
  • Travel Medicine (85)
  • Upper Respiratory Tract Infections (162)
  • Vaccines (280)
  • West Nile Virus (9)
1 - 15 of 34 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Hepatitis C Treatment Overview July 2019
Article: Be Vigilant When Screening for Drug Interactions With Hep C Meds July 2019
Technician Tutorial: Med Administration: Timing is Everything June 2018
Chart: Hepatitis B Vaccination: Who Gets What and When? May 2018
Article: Recommend a Hep B Booster in Some High-Risk Patients May 2018
Article: Get Ready for Hep C Meds Maviret and Vosevi October 2017
Commentary: Risk of Hepatitis B Reactivation With Hepatitis C Drugs April 2017
Article: Put Warnings About Liver Damage With Hep C Meds Into Perspective April 2017
Article: Limit PPI Doses With New Hep C Med Epclusa September 2016
Other: Specialty Drugs: A Primer for Pharmacists and Technicians April 2016
PL Voices: Antiviral Regimens for Hepatitis C April 2016
Chart: FAQs About Specialty Meds April 2016
Article: Watch Statin Doses With New Hepatitis C Med Zepatier April 2016
Article: Watch for Insurance Flags or Rejects for Specialty Meds April 2016
Article: Be Aware of Possible Liver Failure with Holkira Pak or Technivie February 2016
  • 1
  • 2
  • 3
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved